Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

Manchanda, R; Patel, S; Gordeev, VS; Antoniou, AC; Smith, S; Lee, A; Hopper, JL; ... Legood, R; + view all Manchanda, R; Patel, S; Gordeev, VS; Antoniou, AC; Smith, S; Lee, A; Hopper, JL; MacInnis, RJ; Turnbull, C; Ramus, SJ; Gayther, SA; Pharoah, PDP; Menon, U; Jacobs, I; Legood, R; - view fewer (2018) Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. Journal of the National Cancer Institute (JNCI) 10.1093/jnci/djx265 . (In press).

http://ift.tt/2FsDRnf